Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylaxis Regimens for Pediatric Hemophilia A
NCT02727647Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- May 2015
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of antihemophilic factor human in hemophilia A, sponsored by Chulalongkorn University. Started May 2015; status: completed.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02727647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02727647.